Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)

Italy flag Italy · Delayed Price · Currency is EUR
52.50
-0.80 (-1.50%)
At close: Jul 21, 2025
-1.50%
Market Cap2.71B
Revenue (ttm)767.47M
Net Income (ttm)140.02M
Shares Outn/a
EPS (ttm)2.74
PE Ratio19.32
Forward PE20.14
Dividend0.76 (1.44%)
Ex-Dividend DateJul 14, 2025
Volumen/a
Average Volumen/a
Openn/a
Previous Close53.30
Day's Rangen/a
52-Week Range45.95 - 55.59
Betan/a
RSI29.84
Earnings DateJul 24, 2025

About BIT:1ROVI

Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+,... [Read more]

Industry Pharmaceutical Preparations
Founded 1946
Employees 2,197
Stock Exchange Borsa Italiana
Ticker Symbol 1ROVI
Full Company Profile

Financial Performance

In 2024, BIT:1ROVI's revenue was 763.75 million, a decrease of -7.93% compared to the previous year's 829.51 million. Earnings were 136.88 million, a decrease of -19.64%.

Financial Statements

News

There is no news available yet.